-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Bone Biologics Corp quarterly/annual Earnings Per Share, Diluted history and growth rate from 2022 to 2023.
- Bone Biologics Corp Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -2.37 USD/shares, a 51.6% increase year-over-year.
- Bone Biologics Corp Earnings Per Share, Diluted for the twelve months ending September 30, 2024 was 28.3 USD/shares.
- Bone Biologics Corp annual Earnings Per Share, Diluted for 2023 was -34 USD/shares, a 9.18% decline from 2022.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)